[vii], 44 p.
Authors
- Citation
- World Health Organization . (2024). Health technologies gaps and strengthening research and development systems: WHO Product Development Partnerships Forum, meeting report, 2-3 October 2023. World Health Organization. https://iris.who.int/handle/10665/379555 . License: CC BY-NC-SA 3.0 IGO
- ISBN
- 9789240100992 (electronic version) 9789240101005 (print version)
- Pages
- 53
- Published in
- Switzerland
- Rights
- CC BY-NC-SA 3.0 IGO
- Rights Holder
- World Health Organization
- Rights URI
- https://creativecommons.org/licenses/by-nc-sa/3.0/igo
Table of Contents
- List of abbreviations 5
- Executive summary 6
- Background and objectives of the forum 9
- Session 1. Health technologies gaps in key areas for poverty-related diseases 10
- HIV/AIDS, hepatitis and sexually transmitted infections 10
- Tuberculosis: vaccines, screening, testing, diagnosis and treatment 10
- Neglected tropical diseases: challenges and working towards progress 11
- Malaria: work of the Global Malaria Programme on preferred product characteristics 12
- Session 1 Discussion 13
- Session 2: How to close the health technologies gaps 14
- Global Antibiotic Research and Development Partnership 14
- Access to Advanced Health Institute 14
- International AIDS Vaccine Initiative 15
- Medicines for Malaria Venture 16
- European Vaccine Initiative 16
- FIND, the global alliance for diagnostics 17
- TuBerculosis Vaccine Initiative 18
- Coalition for Epidemic Preparedness Innovations 19
- Session 2 Discussion 19
- Session 3. Strengthening research and development systems and the role of product development partnerships 22
- Concept Foundation 23
- HIV Vaccine Trials Network 23
- Drugs for Neglected Diseases Initiative 24
- International Vaccine Institute 24
- Research for Health Department, Science Division, WHO 25
- Session 3 Discussion 25
- Session 4. WHO guidelines and prequalification 27
- Product development partnerships’ perspectives on WHO prequalification and guidelines processes 27
- WHO Department for Immunization, Vaccines, and Biologicals 28
- Session 4 Discussion 30
- Session 5. Fostering collaboration between product development partnerships and WHO 31
- WHO Updates 31
- Session 5 Discussion 32
- Session 6. WHO–product development partnerships–funders collaboration: a roadmap to success 34
- WHO’s Global Accelerator for Paediatric Formulations Network 34
- International AIDS Vaccine Initiative 34
- Population Council 35
- United Kingdom Foreign, Commonwealth & Development Office 35
- Wellcome Trust 37
- WHO Science Division 37
- Session 6 Discussion 38
- References 39
- Annex 1. Agenda 42
- Annex 2. List of participants 48
